Literature DB >> 9537273

Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia.

A Bartoloni1, F Cutts, S Leoni, C C Austin, A Mantella, P Guglielmetti, M Roselli, E Salazar, F Paradisi.   

Abstract

OBJECTIVE: To determine the incidence of antimicrobial-resistant, nonpathogenic Escherichia coli among healthy children aged 6-72 months in Camiri town and a rural village, Javillo, in south-eastern Bolivia.
METHOD: A community-based survey: stool samples were obtained from 296 healthy children selected by modified cluster sampling in Camiri and all 25 eligible children in Javillo. E. coli isolates were tested for antimicrobial susceptibility according to the standard disc diffusion method. By a questionnaire survey of 12 pharmacies and by using simulated patients, we investigated the antimicrobial availability and the usage patterns in Camiri town.
RESULTS: In Camiri, over 90%, and in Javillo over 70% of children carried E. coli resistant to ampicillin, trimethoprim-sulphamethoxazole (TMP/SMX) or tetracycline. Overall, 63% of children carried E. coli with multiple resistance to ampicillin, TMP/SMX, tetracycline and chloramphenicol. In the simulated patients study, antimicrobials were dispensed inappropriately for 92% of adults and 40% of children with watery diarrhoea, and were under-prescribed for males with urethral discharge (67%) or females with fever and dysuria (58%). The dose and/or duration of antimicrobials dispensed was almost always too low.
CONCLUSION: Our study showed a disturbingly high prevalence of carriage of nonpathogenic E. coli resistant to antimicrobials. The prevalence of resistance to ampicillin and TMP/SMX was higher than that previously reported in developing countries. The existence of a large reservoir of resistance genes in healthy individuals in developing countries represents a threat to the success of antimicrobial therapy throughout the world. Programmes to improve rational and effective drug use in developing countries are urgently needed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9537273     DOI: 10.1046/j.1365-3156.1998.00201.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  29 in total

1.  Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

Authors:  Jessica C Seidman; Christian L Coles; Ellen K Silbergeld; Joshua Levens; Harran Mkocha; Lashaunda B Johnson; Beatriz Muñoz; Sheila K West
Journal:  Int J Epidemiol       Date:  2014-03-21       Impact factor: 7.196

2.  High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru.

Authors:  Theresa J Ochoa; Joaquím Ruiz; Margarita Molina; Luis J Del Valle; Martha Vargas; Ana I Gil; Lucie Ecker; Francesca Barletta; Eric Hall; Thomas G Cleary; Claudio F Lanata
Journal:  Am J Trop Med Hyg       Date:  2009-08       Impact factor: 2.345

Review 3.  Non-prescription antimicrobial use worldwide: a systematic review.

Authors:  Daniel J Morgan; Iruka N Okeke; Ramanan Laxminarayan; Eli N Perencevich; Scott Weisenberg
Journal:  Lancet Infect Dis       Date:  2011-06-12       Impact factor: 25.071

4.  Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study.

Authors:  Henry D Kalter; Robert H Gilman; Lawrence H Moulton; Anna R Cullotta; Lilia Cabrera; Billie Velapatiño
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

5.  Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru.

Authors:  Lucia Pallecchi; Monica Malossi; Antonia Mantella; Eduardo Gotuzzo; Christian Trigoso; Alessandro Bartoloni; Franco Paradisi; Göran Kronvall; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  "Practical knowledge" and perceptions of antibiotics and antibiotic resistance among drugsellers in Tanzanian private drugstores.

Authors:  Nina Viberg; Willbrord Kalala; Phare Mujinja; Göran Tomson; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2010-09-16       Impact factor: 3.090

7.  Risk factors for antibiotic-resistant E. coli in children in a rural area.

Authors:  J C Seidman; P Anitha K; R Kanungo; A L Bourgeois; C L Coles
Journal:  Epidemiol Infect       Date:  2008-11-12       Impact factor: 2.451

8.  Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia.

Authors:  Alessandro Bartoloni; Lucia Pallecchi; Marta Benedetti; Connie Fernandez; Yolanda Vallejos; Elisa Guzman; Ana Liz Villagran; Antonia Mantella; Chiara Lucchetti; Filippo Bartalesi; Marianne Strohmeyer; Angela Bechini; Herlan Gamboa; Hugo Rodríguez; Torkel Falkenberg; Göran Kronvall; Eduardo Gotuzzo; Franco Paradisi; Gian Maria Rossolini
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

9.  Antibiotic resistance among Escherichia coli isolates from stool samples of children aged 3 to 14 years from Ujjain, India.

Authors:  Pragya Shakya; Peter Barrett; Vishal Diwan; Yogyata Marothi; Harshada Shah; Neeraj Chhari; Ashok J Tamhankar; Ashish Pathak; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2013-10-14       Impact factor: 3.090

10.  Antibacterial resistance, Wayampis Amerindians, French Guyana.

Authors:  Karine Grenet; Didier Guillemot; Vincent Jarlier; Brigitte Moreau; Stéphane Dubourdieu; Raymond Ruimy; Laurence Armand-Lefevre; Pierre Bau; Antoine Andremont
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.